HOYA Corporation (TYO: 7741)
Japan
· Delayed Price · Currency is JPY 21,140
+125 (0.59%)
Jan 21, 2025, 1:04 PM JST
HOYA Corporation Revenue
HOYA Corporation had revenue of 214.66B JPY in the quarter ending September 30, 2024, with 9.51% growth. This brings the company's revenue in the last twelve months to 812.74B, up 10.33% year-over-year. In the fiscal year ending March 31, 2024, HOYA Corporation had annual revenue of 762.61B with 5.39% growth.
Revenue (ttm)
812.74B
Revenue Growth
+10.33%
P/S Ratio
9.15
Revenue / Employee
22.76M
Employees
35,702
Market Cap
7,352.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 762.61B | 39.03B | 5.39% |
| Mar 31, 2023 | 723.58B | 62.12B | 9.39% |
| Mar 31, 2022 | 661.47B | 113.55B | 20.72% |
| Mar 31, 2021 | 547.92B | -28.63B | -4.96% |
| Mar 31, 2020 | 576.55B | 10.74B | 1.90% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,142.35B |
| Daiichi Sankyo Company | 1,758.07B |
| Takeda Pharmaceutical Company | 4,546.08B |
| Terumo | 986.67B |
| Otsuka Holdings | 2,269.56B |
| Astellas Pharma | 1,772.16B |
| Olympus | 973.60B |
| Shionogi & | 418.51B |